Cantitate/Preț
Produs

Drug Stereochemistry: Analytical Methods and Pharmacology, Third Edition: Drugs and the Pharmaceutical Sciences

Editat de Krzysztof Jozwiak, W. J. Lough, Irving W. Wainer
en Limba Engleză Hardback – 23 apr 2012
Drug Stereochemistry: Analytical Methods and Pharmacology, Third Edition covers all aspects of chiral drugs from academic, governmental, industrial, and clinical perspectives, reflecting the many advances in techniques and methodology.
Topics include:
  • The use of enzymes in the synthesis and resolution of enantiometrically pure compounds in drug discovery
  • How stereochemistry impacts decisions made in the absorption, distribution, metabolism, excretion, and toxicity (ADMET) stages of drug discovery
  • Pharmacokinetics and pharmacodynamics and the issues faced during the final stages of the drug development process
  • The impact of the International Conference on Harmonisation (ICH) on the use of single isomer drugs
  • Chiral switches
  • The concept of molecular chiral recognition and how it affects the separation and behavior of stereochemically pure drugs
  • Patent issues surrounding chiral switches and the marketing of single enantiomer switches
The book provides a solid background on stereochemistry, from its early history, including an overview of terms and concepts, to the current drug development process, legal and regulatory issues, and the new stereoisomeric drugs. It is a one-stop reference for pharmaceutical scientists and chemists working with chiral drug molecules.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 31391 lei  6-8 săpt.
  CRC Press – 14 oct 2024 31391 lei  6-8 săpt.
Hardback (1) 98405 lei  6-8 săpt.
  CRC Press – 23 apr 2012 98405 lei  6-8 săpt.

Din seria Drugs and the Pharmaceutical Sciences

Preț: 98405 lei

Preț vechi: 133053 lei
-26% Nou

Puncte Express: 1476

Preț estimativ în valută:
18833 19868$ 15695£

Carte tipărită la comandă

Livrare economică 02-16 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781420092387
ISBN-10: 1420092383
Pagini: 330
Ilustrații: 29 b/w images
Dimensiuni: 152 x 229 x 25 mm
Greutate: 0.61 kg
Ediția:Revizuită
Editura: CRC Press
Colecția CRC Press
Seria Drugs and the Pharmaceutical Sciences

Locul publicării:Boca Raton, United States

Public țintă

Professional Practice & Development

Cuprins

Introduction: The Early History of Stereochemistry: From the Discovery of Molecular Asymmetry and the First Resolution of a Racemate by Pasteur to the Asymmetrical Chiral Carbon of Van’t Hoff and Le Bel. Stereochemical Terms and Concepts: An Overview. Molecular Chiral Recognition: An Introduction and Overview. The Role of Stereo-Chemistry in the Development of ACE Inhibitors: Nature to Clinic. The Separation, Preparation and Identification of Stereochemically Pure Drugs: Indirect Methods for the Chromatographic Resolution of Drug Enantiomers: Synthesis and Separation of Diastereo-Metric Derivatives. The Direct Resolution of Enantiometric Drugs by Chiral Phase Gas Chromatography. HPLC Chiral Stationary Phases for the Stereochemical Resolution of Enantiometric Compounds: The Current State of the Art. Enantioselective Separations by Capillary Electrophoresis. Recent Advances in the Synthesis of Enantiomerically Pure Compounds. Production Scale Preparation of Enantiomerically Pure Compounds by Chromatography and Synthetic Approaches. Spectrometric Identification and Characterization of Chiral Molecules. Pharmacokinetic and Pharmacodynamic Differences Between Drug Stereoisomers: Stereochemical Considerations in the ADMET Stage of Drug Development. Stereoselective Biotransformations: Toxico-Logical Consequences and Implications. Stereoselective Interactions with Enzymes and Their Use in Drug Development. Stereoselective Transport of Drugs Across Epithelia. Clinical Pharmacokinetics and pharmacodynamics of Stereoisomeric Drugs. Industrial and Regulatory Perspectives on Single Isomer Drugs: Regulatory Perspective of the Development of New Stereoisomeric Drugs. Stereochemically Pure Drugs Versus Racemates: An Overview. The Development and Marketing of Single Isomer Drugs vs Racemates: A Legal Perspective.

Notă biografică

Professor Krzysztof Jóźwiak is head of laboratory of medicinal chemistry and neuroengineering of Medical University of Lublin, Poland
Dr W John Lough is reader in pharmaceutical analysis in the Department of Pharmacy, Health and Well-Being at the University of Sunderland, UK
Irving W. Wainer, Ph.D. is senior investigator, in the Bioanalytical Chemistry and Drug Discovery Section, Laboratory for Clinical Investigation, National Institute of Aging/National Institutes of Health


Descriere

This third edition has been updated to cover all aspects of chiral drugs from the academic, governmental, industrial, and clinical perspectives. New topics include the use of enzymes in the synthesis and resolution of enantiometrically pure compounds in drug discovery, how stereochemistry impacts decisions made in the absorption, distribution, metabolism, excretion, and toxicity (ADMET) stages of drug discovery, and issues faced during the final stages of the drug development process. It also discusses the impact of International Conference on Harmonisation (ICH) on the use of single isomer drugs, chiral switches, molecular chiral recognition, and legal perspectives.